Elite Pharmaceuticals Inc (ELTP)

[no2koolaid]

I absolutely concur. It is not an always thing and it depends on a number of factors...the type of drug, the competitors, the size and growth in the market. I would never say anything is an absolute; I was merely indicating that the p/s for the approval of ELI200 is not absolutely baked in.

I also expect that, even with an increase upon approval, given the number of short term investors (I did not use the pejorative term flipper, because not all are), I expect some to take profits and the p/s to fall to some new, but higher level. Still, with the arrows in Elite's quiver, my view/investment is based on how the business is positioned to succeed and I believe the approval of ELI200 is proof their tech works. That means they are likely to submit this calendar year the two additional drugs Nasrat has mentioned and it makes their candidacy for either a partnership or a buyout viable, if not likely in the near term. Which raises the question - How near term? No idea. However, I would rather hold my shares for that price level.

Thanks for the input...